TKNO MEXC RealStocks
Own real TKNO shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 08:30:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Alpha Teknova, Inc. (TKNO) operates in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector and is listed on NASDAQ. The stock is currently priced at $7.86, with a market capitalization of $481.21M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.91 to $9.48. This page covers its latest market performance, valuation, price trends and company information.
$481.21M | |
$7.51 | |
$8.01 | |
$7.51 | |
$7.65 | |
247.93K | |
439.64K | |
-- | |
$9.48 | |
$1.91 | |
-- | |
2026-09-30 |
Alpha Teknova, Inc. (TKNO) last closed at $7.86 as of 2026-11-19 00:43:00, up 2.88% ($0.22) from the previous close of $7.65.
During the latest regular trading session, TKNO traded between $7.51 and $8.01, with a volume of 247.93K shares. The closing price was near the upper end and near the upper end of its 52-week range.
Over the past seven days, Alpha Teknova, Inc. (TKNO) moved from $8.73 to $7.86, representing a decline of 10.02% ($0.88).
The stock traded between $7.51 and $9.34 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 352.42 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 78.5%
TKNO is currently trading at $7.86, placing it 78.5% of the way from its 52-week low of $1.91 to its 52-week high of $9.48. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.
| Industry | IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES |
| Employees | 158 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Alpha Teknova, Inc. (TKNO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to TKNO, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between TKNO shares and USD.
TKNO Shares to USD
1.00 TKNO shares = 7.855 USD
Calculations are estimates based on the latest available price and are for reference only.